Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Phenylpropene derivative found in essential oil...
Juvenille insect growth hormone analog.
Diterpene found in Taxus, used to synthesize ta...
Endogenous peptide hormone, involved in cell gr...
NO donor.
Decreases expression of MMPs, PGE2, and COX-2, ...
Nucleoside (adenosine) analog; viral DNA polyme...
Protein translation inhibitor, peptidyl transfe...
Antimicrobial peptide found in amphibians.
Mycotoxin produced by species of Fusarium; pote...
Diterpene found in coffee beans.
ALK inhibitor.
Peptide; α4β1 integrin activator.
TRPA1 antagonist
Peptide, oxytocin analog; potential OXTR agonis...
Phenolic phytoalexin found in soy, grapes, and ...
STAT3 inhibitor.
Potential ATP-sensitive K+ channel blocker, pot...
Peptide; galanin antagonist.
RARα/β agonist.